🇺🇸 FDA
Patent

US 8993768

Tropolone compounds for treating or preventing retroviral infection

granted A61KA61K31/122A61K31/4164

Quick answer

US patent 8993768 (Tropolone compounds for treating or preventing retroviral infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/122, A61K31/4164, A61K31/4453, A61K45/06